Month: February 2026

In collaboration with IASMED and BB Binomika, Prodia CRO successfully delivered a two-day Good Clinical Practice (GCP) Training held on February 4–5, 2026, at Four Points Hotel Bekasi, Indonesia.

The program convened 55 participants from hospitals and Clinical Research Units across Indonesia, providing a structured forum for professional exchange and capacity building in clinical research. The training was carefully designed to reinforce adherence to the highest standards of ethics, regulatory compliance, and research quality, and was delivered through comprehensive discussions alongside expert-led sessions that emphasized the practical implementation of Good Clinical Practice (GCP) in real-world clinical settings. Notably, all participants successfully passed the GCP examination, marking a significant achievement that reflects the growing competence and professionalism of Indonesia’s clinical research community.

This collaborative initiative represents an important milestone in strengthening professional capabilities, fostering sustainable research partnerships, and supporting the continued advancement of ethical, high-quality clinical research standards nationwide.

#BBBinomika #GCPTraining #ClinicalResearch #Collaboration #Indonesia #ProdiatheCRO #IndonesiaClinicalTrial

As a pioneer of local Clinical Research Organization (CRO) in Indonesia, PT Prodia Diacro Laboratories (Prodia CRO) has once again been honored by Frost & Sullivan as the Company of the Year 2025 for best practices in the Indonesian clinical research organization industry [See the full list of Company of the Year 2025 winners by Frost & Sullivan]. This achievement marks eight consecutive years of longstanding recognition from Frost & Sullivan, which began with the Best Indonesia CRO awards in 2014 and 2015, followed by the Indonesia CRO Customer Value Leadership Awards in 2020 and 2021, and the Company of the Year Awards in 2022, 2023, 2024, and 2025.

“As Indonesia emerges as a regional clinical research hub, PT Prodia Diacro Laboratories stands at the forefront—combining international standards with deep local expertise to unlock the country’s full research potential. Through integrated services, CAP-accredited laboratories, and a pioneering site management model, Prodia is not only bridging global sponsors with Indonesia’s diverse patient population but shaping the future of clinical trials across Southeast Asia.”      
— Unmesh Lal, Vice President, Healthcare & Life Sciences, Frost & Sullivan.

Frost & Sullivan’s evaluation reflects how Prodia CRO continues to bridge Indonesia’s potential with global research excellence. Through international-standard–based and wide-ranging integrated clinical trial services, a wide network of CAP-accredited laboratories supported by its sister company, Prodia Widyahusada, and a scalable site management model, Prodia strengthens site readiness and investigator capability across Indonesia.

Frost & Sullivan also recognized Prodia CRO’s commitment to operational excellence, strategic foresight, and ecosystem development, which enable the company to deliver consistent, high-quality clinical trial solutions for both local and global clients, advancing Indonesia’s role as an emerging hub for global clinical research. [Discover more about Prodia the CRO’s Company of the Year Award].

Watch the highlight video of Prodia CRO’s recognition by Frost & Sullivan below.